ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 83 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,722,025 | +61.9% | 9,248,250 | 0.0% | 18.03% | +40.5% |
| Q2 2023 | $9,710,663 | -12.5% | 9,248,250 | 0.0% | 12.83% | +2.3% |
| Q1 2023 | $11,097,900 | -20.0% | 9,248,250 | 0.0% | 12.55% | -5.1% |
| Q4 2022 | $13,872,375 | -52.1% | 9,248,250 | 0.0% | 13.22% | -56.2% |
| Q3 2022 | $28,947,000 | +37.9% | 9,248,250 | +44.5% | 30.22% | +28.4% |
| Q2 2022 | $20,986,000 | -28.1% | 6,398,250 | 0.0% | 23.53% | -12.3% |
| Q1 2022 | $29,176,000 | -29.1% | 6,398,250 | +12.9% | 26.83% | -16.5% |
| Q4 2021 | $41,130,000 | – | 5,665,221 | – | 32.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |